Nearly Half of U.S. COVID-19 Cases Now Caused by JN.1 Variant

Follow Drugslib on

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

THURSDAY, Dec. 28, 2023 -- The JN.1 variant, a descendant of the variant BA.2.86, now accounts for 44 percent of COVID-19 cases, up from roughly 7 percent in late November, the latest data from the U.S. Centers for Disease Control and Prevention show.

The speed at which the JN.1 variant has spread this month suggests it may spread more easily and be better at evading immune systems than other circulating variants, according to a recent CDC report. "It is too early to know whether or to what extent JN.1 will cause an increase in infections or hospitalizations," the CDC said in its report.

Luckily, JN.1 does not seem to be causing more severe illness yet. Additionally, the updated COVID-19 vaccines that were released in September produce antibodies that work against JN.1, which is distantly related to the XBB.1.5 variant the tweaked vaccines target.

Despite the fact that JN.1 may not cause more severe disease than other variants, hospitalizations have started creeping up recently. For the week of Dec. 10, there were just under 26,000 COVID-19-linked hospitalizations, a 10 percent increase from about 23,000 hospitalizations the week before. However, those numbers are still far lower than they were during the peak of the tripledemic last winter, when COVID-19, flu, and respiratory syncytial virus cases all surged simultaneously.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-29 22:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords